Correlation Between Monopar Therapeutics and Hypercharge Networks

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Monopar Therapeutics and Hypercharge Networks at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Monopar Therapeutics and Hypercharge Networks into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Monopar Therapeutics and Hypercharge Networks Corp, you can compare the effects of market volatilities on Monopar Therapeutics and Hypercharge Networks and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Monopar Therapeutics with a short position of Hypercharge Networks. Check out your portfolio center. Please also check ongoing floating volatility patterns of Monopar Therapeutics and Hypercharge Networks.

Diversification Opportunities for Monopar Therapeutics and Hypercharge Networks

-0.37
  Correlation Coefficient

Very good diversification

The 3 months correlation between Monopar and Hypercharge is -0.37. Overlapping area represents the amount of risk that can be diversified away by holding Monopar Therapeutics and Hypercharge Networks Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Hypercharge Networks Corp and Monopar Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Monopar Therapeutics are associated (or correlated) with Hypercharge Networks. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Hypercharge Networks Corp has no effect on the direction of Monopar Therapeutics i.e., Monopar Therapeutics and Hypercharge Networks go up and down completely randomly.

Pair Corralation between Monopar Therapeutics and Hypercharge Networks

Given the investment horizon of 90 days Monopar Therapeutics is expected to generate 1.14 times more return on investment than Hypercharge Networks. However, Monopar Therapeutics is 1.14 times more volatile than Hypercharge Networks Corp. It trades about 0.38 of its potential returns per unit of risk. Hypercharge Networks Corp is currently generating about -0.01 per unit of risk. If you would invest  2,360  in Monopar Therapeutics on November 5, 2024 and sell it today you would earn a total of  2,034  from holding Monopar Therapeutics or generate 86.19% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy95.0%
ValuesDaily Returns

Monopar Therapeutics  vs.  Hypercharge Networks Corp

 Performance 
       Timeline  
Monopar Therapeutics 

Risk-Adjusted Performance

20 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Monopar Therapeutics are ranked lower than 20 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, Monopar Therapeutics reported solid returns over the last few months and may actually be approaching a breakup point.
Hypercharge Networks Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Hypercharge Networks Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Monopar Therapeutics and Hypercharge Networks Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Monopar Therapeutics and Hypercharge Networks

The main advantage of trading using opposite Monopar Therapeutics and Hypercharge Networks positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Monopar Therapeutics position performs unexpectedly, Hypercharge Networks can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Hypercharge Networks will offset losses from the drop in Hypercharge Networks' long position.
The idea behind Monopar Therapeutics and Hypercharge Networks Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.

Other Complementary Tools

Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges